Literature DB >> 22914388

Cerebral injury in twin-twin transfusion syndrome treated with fetoscopic laser surgery.

Marjolijn Spruijt1, Sylke Steggerda, Mirjam Rath, Erik van Zwet, Dick Oepkes, Frans Walther, Enrico Lopriore.   

Abstract

OBJECTIVE: To estimate the incidence and risk factors for cerebral lesions in monochorionic twins with twin-twin transfusion syndrome treated with fetoscopic laser surgery compared with dichorionic twins.
METHODS: We performed a case-control study on cerebral injury detected by postnatal cranial ultrasonography in monochorionic twin neonates with twin-twin transfusion syndrome treated with a laser compared with a control group of dichorionic twin neonates matched for gestational age at birth. Severe cerebral lesions were defined as the presence of at least one of the following: intraventricular hemorrhage grade III, periventricular hemorrhagic infarction, periventricular leukomalacia grade II or greater, porencephalic cysts, arterial stroke, ventricular dilatation, or a combination of these.
RESULTS: From 2004 until 2011, 267 twin neonates with twin-twin transfusion syndrome could be included and matched with 267 dichorionic twin neonates. Incidence of severe cerebral lesions in the twin-twin transfusion syndrome group and control group was 8.6% (23 of 267) and 6.7% (18 of 267), respectively (P=.44). Multivariable analysis revealed that only gestational age at birth was independently associated with increased risk for severe cerebral lesions (odds ratio [OR] 1.35 for each week, 95% confidence interval [CI] 1.14-1.59, P<.01). In 52.2% (12 of 23), the cerebral lesions in the twin-twin transfusion syndrome group were of antenatal origin compared with 16.7% (3 of 18) in the control group (OR 8.00, 95% CI 1.42-45.06, P=.02).
CONCLUSION: Incidence of severe cerebral lesions in twin-twin transfusion syndrome treated with laser is similar to a matched control group and is independently associated with prematurity. In contrast to dichorionic twins, cerebral injury in twins with twin-twin transfusion syndrome most often occurs antenatally.

Entities:  

Mesh:

Year:  2012        PMID: 22914388     DOI: 10.1097/AOG.0b013e31825b9841

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Incidence and Causes of Intentional Fetal or Neonatal Demise in Twin-Twin Transfusion Syndrome.

Authors:  Marjolijn S Spruijt; Ellen Tameeris; De-Peng Zhao; Johanna M Middeldorp; Monique C Haak; Dick Oepkes; Enrico Lopriore
Journal:  Fetal Diagn Ther       Date:  2017-03-11       Impact factor: 2.587

2.  Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome.

Authors:  Lisa Hui; Heather C Wick; Kenneth J Moise; Anthony Johnson; Francois Luks; Sina Haeri; Kirby L Johnson; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2013-06-04       Impact factor: 3.050

3.  Long-Term Neurodevelopmental Outcome in Twin-to-Twin Transfusion Syndrome: Is there still Room for Improvement?

Authors:  Marjolijn S Spruijt; Enrico Lopriore; Ratna N G B Tan; Femke Slaghekke; Frans J C M Klumper; Johanna M Middeldorp; Monique C Haak; Dick Oepkes; Monique Rijken; Jeanine M M van Klink
Journal:  J Clin Med       Date:  2019-08-15       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.